Related Experiment Videos
[New blood pressure lowering drugs in childhood]
Insights
New antihypertensive agents, including angiotensin converting-enzyme inhibitors and calcium antagonists, offer improved treatment for pediatric hypertension. Captopril and nifedipine show particular promise for managing severe and acute hypertension in children, respectively.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Cardiology
Context:
- Hypertension in children presents unique challenges for effective treatment.
- Recent advancements in antihypertensive pharmacotherapy have expanded treatment options.
- Angiotensin converting-enzyme inhibitors and calcium antagonists represent key therapeutic classes.
Purpose:
- To review the efficacy and safety of novel antihypertensive agents in pediatric populations.
- To highlight the role of angiotensin converting-enzyme inhibitors (ACEIs) and calcium antagonists (CCBs) in managing childhood hypertension.
- To compare the utility of captopril and nifedipine for specific hypertensive conditions in children.
Summary:
- Angiotensin converting-enzyme inhibitors, such as captopril, are increasingly used for severe pediatric hypertension, with low doses minimizing side effects.
- Nifedipine, a calcium antagonist, is recommended as a first-line treatment for acute hypertension in infants and children due to its rapid and safe efficacy via sublingual administration.
- Both ACEIs and CCBs have demonstrated successful application in treating both acute and chronic hypertension in pediatric patients.
Impact:
- Provides clinicians with evidence-based guidance on utilizing novel antihypertensive drugs in pediatric care.
- Contributes to improved management strategies for hypertension in infants and children.
- Supports the development of safer and more effective treatment protocols for pediatric hypertensive emergencies and chronic conditions.
Abstract:
The treatment by antihypertensive agents has recently been improved by the introduction of angiotensin converting-enzyme inhibitors, and of calcium antagonists, which have been applied successfully in children with acute and chronic hypertension. The converting enzyme inhibitor captopril is used increasingly for the treatment of severe forms of persistent hypertension in children. Side effects from this drug can largely be avoided by using low daily doses. The calcium-antagonist nifedipine can now be regarded as the drug of choice in the treatment of acute elevation of blood pressure in infants and children. For this indication it appears to be superior to other drugs because of its prompt and safe efficacy after sublingual administration.